Dr. Simeon Jaggernauth discusses how to detect and treat this rare but aggressive form of Breast Cancer on Good Morning Texas.

Prof Jessica Leung speaks to ecancer about the features of inflammatory breast cancer and triple-negative breast cancer. She explains the morphological features of both cancers and talks about their impact on the patient population.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Beth Overmoyer, MD, and Filipa Lynce, MD, along with their colleagues and patients, celebrate the advances in research, treatment, and support in the decade since the IBC Program was founded.

“I know they say October is breast cancer awareness month, but for those of us with metastatic disease, that’s every month. Our cancer is here all year.” Jennifer Cordts was diagnosed with stage IV Inflammatory Breast Cancer in November 2015. A mother of two daughters, Jennifer is also a Board member of the Inflammatory Breast Cancer Research Foundation, she runs a support group at Baylor Hospital, volunteers for Meals on Wheels and is a breast cancer advocate.

Inflammatory breast cancer (IBC) is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed. IBC is more difficult to diagnose than other types of breast cancer, and there is a lack of understanding of the disease… even among the medical community. Only increased awareness and education, and more research—including participation in clinical trials—can help improve outcomes and quality of life for IBC patients.

This video is part of the Metastatic Breast Cancer Alliance's Here All Year campaign. Breast Cancer Awareness Month is just October, but we're Here All Year.

The Metastatic Breast Cancer Alliance strives to ensure that all metastatic breast cancer patients and their caregivers know how to and are able to access the care and services they need from a responsive and well-informed healthcare system. We are doing that by working to build understanding of Metastatic Breast Cancer and how it differs from early stage breast cancer among those diagnosed—as well as their families, health care providers, researchers, and health policy makers and influencers.

Each month, our Here All Year campaign explores a new topic around metastatic breast cancer—from myth and stigma busters, to new research and strategies for improving outcomes. Want to help make a difference for people living with MBC, all year long? Dig deeper into the research, explore the available resources and share them on your social and email channels.

Jasmine Jeffries was diagnosed in 2019 with stage IV Inflammatory Breast Cancer ER, PR positive HER2 negative with metastases to her vertebrae. While the cancer diagnosis was one of the biggest blows Jasmine has ever felt, she didn’t let it stop her. Through this journey Jasmine has begun to advocate for women with Metastatic Breast Cancer. She became an Angel advocate with the Tigerlily Foundation, focusing on ending disparities among African American women and becoming knowledgeable about MBC and using her voice to educate others. She lives a life that exemplifies her faith in God and has a strong foundation that she relies on every day of her life. Jasmine enjoys singing, traveling, hanging out with family and friends, but most importantly being in great company enjoying life and every moment.

Inflammatory breast cancer (IBC) is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed. IBC is more difficult to diagnose than other types of breast cancer, and there is a lack of understanding of the disease… even among the medical community. Only increased awareness and education, and more research—including participation in clinical trials—can help improve outcomes and quality of life for IBC patients.

This video is part of the Metastatic Breast Cancer Alliance's Here All Year campaign. Breast Cancer Awareness Month is just October, but we're Here All Year.

The Metastatic Breast Cancer Alliance strives to ensure that all metastatic breast cancer patients and their caregivers know how to and are able to access the care and services they need from a responsive and well-informed healthcare system. We are doing that by working to build understanding of Metastatic Breast Cancer and how it differs from early stage breast cancer among those diagnosed—as well as their families, health care providers, researchers, and health policy makers and influencers.

Each month, our Here All Year campaign explores a new topic around metastatic breast cancer—from myth and stigma busters, to new research and strategies for improving outcomes. Want to help make a difference for people living with MBC, all year long? Dig deeper into the research, explore the available resources and share them on your social and email channels.

Learn about the IBC Scoring System, a proposed, first-of-its kind tool for IBC. This system is being developed to increase diagnostic accuracy, guide treatment decisions and inclusion in clinical trials and aid research.